.Medical Scientific Liaison Zona NoresteMedical Scientific Liaison Zona Noreste Apply locations: BarcelonaTime type: Full timePosted on: Posted TodayTime left to apply: End Date: December 26, 2024 (30+ days left to apply)Job requisition id: R2751730Grade: L2Location: País Vasco, Pamplona, Santander, Zaragoza, y Parte de BarcelonaJob type: Permanent, Full-timeAbout the jobAt Sanofi, we are driven by one purpose – we chase the miracles of science to improve people's lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We never settle and now we are creating a new paradigm with a first-in-class therapy in Autoimmune Diabetes (Type 1 Diabetes).We now present an exciting opportunity for you to go further faster. If you're excited by the prospect of bringing this innovative, first-in-class therapy to more people at risk then we want to hear from you as we build a great team who will work at the intersection of our growth in immune-mediated diseases and disease-modifying therapies in areas of high unmet need.Our Team:We are seeking a highly motivated and visionary leader interested in shaping the management of people at risk of developing/or with T1 diabetes.As a MSL, you will be the trusted scientific partner in the field for external experts and decision-makers (incl. KOLs, Endos, other scientific stakeholders) engaging in mutual scientific exchanges to accelerate data dissemination on a first-in-class therapy in Autoimmune Type 1 Diabetes. You will be primarily responsible to enhance the understanding of the scientific and medical value of our innovative product in the therapeutic area.Your core responsibilities will include:Being the trusted scientific partner to key external experts (incl. KOLs, Endos, other scientific stakeholders), establishing and maintaining robust, long-term peer relationships.Conducting high-touch scientific exchange with experts from key accounts (e.G., KOLs in Centers of Excellence) and beyond (e.G., broader HCP groups/scientific stakeholders outside of Centers of Excellence) to convey a compelling and highly scientific narrative on T1D disease stages, importance of screening and treatment.Engaging with experts from key accounts (e.G., KOLs and Endos and pediatricians in Centers of Excellence) to share scientific data, answer scientific questions and support them in developing best practices (i.E., on infusion protocols).Linking internal partners to external thought leaders for education and research collaboration.Disseminating scientific information including innovative medical education materials and research concepts to KOLs and fostering medical and scientific information exchange between the medical community.Tailoring engagement to the different segments of stakeholders, based on comprehensive stakeholders' mapping (incl. KOLs, Endos, other scientific stakeholders) and local go-to-market model